KR7207940008
KR7207940008
SAMSUNG BIOLOGICS
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 4.556.971.695.180 | 3.497.145.675.780 | 30.3% |
| Cost of Revenue | 2.040.331.283.530 | 1.785.960.975.720 | 14.2% |
| Gross Profit | 2.516.640.411.650 | 1.711.184.700.060 | 47.1% |
| 447.419.144.940 | 389.818.319.400 | 14.8% | |
| Operating Income | 2.069.221.266.710 | 1.321.366.380.660 | 56.6% |
| Pretax Income | 2.118.631.252.680 | 1.384.868.829.740 | 53.0% |
| Net Income Common Stockholders | 1.784.352.060.590 | 1.083.315.885.980 | 64.7% |
| -- | -- | -- | |
| -- | -- | -- |